Mycell Technologies LLC, a leading intellectual property and investment holding company, specializing in the development of proprietary liquid formulations of stable, highly concentrated omega-3s for use in food, beverage, medical and nutritional products, announced today the closing of an institutional non-controlling minority investment providing Mycell Technologies with an infusion of $10 million. Terms of the transaction and investor names were not disclosed.
"We are now positioned for extraordinary growth at Mycell Technologies and Oceans Omega, our flagship ingredient subsidiary," said Benjamin D. Mamola, Chairman and Chief Executive Officer. "We are thankful to have a strategic institutional investor to share in this growth. In the coming weeks, we will be announcing additions to our management team and new partnerships to help continue our strong momentum."